Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Single-cell spatial landscapes of the lung tumour immune microenvironmentNature (London), 2023-02, Vol.614 (7948), p.548-554 [Peer Reviewed Journal]2023. The Author(s). ;Copyright Nature Publishing Group Feb 16, 2023 ;The Author(s) 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-05672-3 ;PMID: 36725934Full text available |
|
2 |
Material Type: Article
|
Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung CancerThe New England journal of medicine, 2020-10, Vol.383 (18), p.1711-1723 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2027071 ;PMID: 32955177Full text available |
|
3 |
Material Type: Article
|
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung CancerThe New England journal of medicine, 2019-11, Vol.381 (21), p.2020-2031 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1910231 ;PMID: 31562796Full text available |
|
4 |
Material Type: Article
|
Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung CancerThe New England journal of medicine, 2022-01, Vol.386 (3), p.241-251 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2112431 ;PMID: 34534430Full text available |
|
5 |
Material Type: Article
|
Antibodies against endogenous retroviruses promote lung cancer immunotherapyNature (London), 2023-04, Vol.616 (7957), p.563-573 [Peer Reviewed Journal]2023. The Author(s). ;Copyright Nature Publishing Group Apr 20, 2023 ;The Author(s) 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-023-05771-9 ;PMID: 37046094Full text available |
|
6 |
Material Type: Article
|
The evolution of lung cancer and impact of subclonal selection in TRACERxNature (London), 2023-04, Vol.616 (7957), p.525-533 [Peer Reviewed Journal]2023. The Author(s). ;Copyright Nature Publishing Group Apr 20, 2023 ;The Author(s) 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-023-05783-5 ;PMID: 37046096Full text available |
|
7 |
Material Type: Article
|
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerThe New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1709937 ;PMID: 28885881Full text available |
|
8 |
Material Type: Article
|
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLCThe New England journal of medicine, 2020-10, Vol.383 (14), p.1328-1339 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1917346 ;PMID: 32997907Full text available |
|
9 |
Material Type: Article
|
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung CancerThe New England journal of medicine, 2018-05, Vol.378 (22), p.2078-2092 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1801005 ;PMID: 29658856Full text available |
|
10 |
Material Type: Article
|
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung CancerThe New England journal of medicine, 2023-02, Vol.388 (6), p.489-498 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2212083 ;PMID: 36780674Full text available |
|
11 |
Material Type: Article
|
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancerNature (London), 2017-05, Vol.545 (7654), p.360-364 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group May 18, 2017 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature22323 ;PMID: 28489825Full text available |
|
12 |
Material Type: Article
|
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLCThe New England journal of medicine, 2023-07, Vol.389 (2), p.137-147 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2304594 ;PMID: 37272535Full text available |
|
13 |
Material Type: Article
|
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLCThe New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1809697 ;PMID: 30280658Full text available |
|
14 |
Material Type: Article
|
Neoadjuvant PD-1 Blockade in Resectable Lung CancerThe New England journal of medicine, 2018-05, Vol.378 (21), p.1976-1986 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1716078 ;PMID: 29658848Full text available |
|
15 |
Material Type: Article
|
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancerNature (London), 2021-12, Vol.600 (7888), p.319-323 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Dec 9, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04135-5 ;PMID: 34819663Full text available |
|
16 |
Material Type: Article
|
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cellsNature (London), 2017-06, Vol.546 (7656), p.168-172 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Jun 1, 2017 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature22359 ;PMID: 28538732Full text available |
|
17 |
Material Type: Article
|
Lung cancer: current therapies and new targeted treatmentsThe Lancet (British edition), 2017-01, Vol.389 (10066), p.299-311 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 21, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)30958-8 ;PMID: 27574741 ;CODEN: LANCAOFull text available |
|
18 |
Material Type: Article
|
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapyNature (London), 2017-11, Vol.551 (7681), p.517-520 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Nov 23, 2017 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature24473 ;PMID: 29132144Full text available |
|
19 |
Material Type: Article
|
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLCThe New England journal of medicine, 2020-01, Vol.382 (1), p.41-50 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1913662 ;PMID: 31751012Full text available |
|
20 |
Material Type: Article
|
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung CancerThe New England journal of medicine, 2020-11, Vol.383 (21), p.2018-2029 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2027187 ;PMID: 33207094Full text available |